Skip to main content

Cardiovascular and Metabolomics Medicine

About the Group

Characterize the cellular and molecular mechanisms that contribute to the development of cardiovascular and metabolic diseases to propose and evaluate new experimental therapies for prevention and treatment in preclinical models, which will lay the scientific basis for conducting clinical studies with patients


Research lines

• Study of novel immuno-modulation and thrombosis mechanisms in cardiovascular and metabolic diseases.
• Characterization of pathological alterations in intracellular calcium management during the development of heart failure and arrhythmias.
• Regulation of energy metabolism and mitochondrial function in cardiovascular and metabolic diseases.
• Development of nanomaterials with biomedical applications in the cardiovascular area.
• Development of new molecules of natural origin and micronutrients for the treatment of cardiovascular and metabolic diseases.

Leader

Gerardo de Jesús García Rivas
 

Core reserchers

Carlos Enrique Guerrero Beltrán
Julio Altamirano Barrera
Luz Leticia Elizondo Montemayor
Noemí García Ramírez
Omar Lozano García

 

Adjunct researchers

Carlos Jerjes Sánchez Díaz
Christian Ivan Silva Platas
Eduardo Vázquez Garza
Elena Cristina González Castillo
Estibalitz Laresgoiti Servitje
Francisco Javier Sierra Valdez
Guillermo Torre Amione
Hugo Jorge Alves Figueiredo
José Carlos Campero Basaldúa
Luis Adolfo Sánchez Trujillo
Martín Rogelio Ramos González
Nestor Rubio Infante
Perla Idalia Pérez Treviño

Publications

Top 5 of publications 2015-2019

- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Authors: Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M., Chen, D., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., Akarca, U., Al Ali, F., Lawati, F., Naamani, K., Alashgar, H., Alavian, S., Alawadhi, S., Sanchez-Avila, J., Saraswat, V., Sarrazin, C., et al.

- Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of post-acute isoproterenol-induced cardiomyopathy
Authors: Willis, B., Salazar-Cantú, A., Silva-Platas, C., Fernández-Sada, E., Villegas, C., Rios-Argaiz, E., González-Serrano, P., Sánchez, L., Guerrero-Beltrán, C., García, N., Torre-Amione, G., García-Rivas, G., & Altamirano, J.

-Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians
Authors: Vazquez-Garza, E., Jerjes-Sanchez, C., Navarrete, A., Joya-Harrison, J., & Rodriguez, D.

- Acute heart failure in the elderly: Differences in clinical characteristics, outcomes, and prognostic factors in the Veritas study
Authors: Metra, M., Cotter, G., El-Khorazaty, J., Davison, B., Milo, O., Carubelli, V., Bourge, R., Cleland, J., Jondeau, G., Krum, H.,  , C., Parker, J., Torre-Amione, G., Van Veldhuisen, D., Rainisio, M., Kobrin, I., McMurray, J., & Teerlink, J.

- Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages
Authors: Escamilla-Rivera, V., Uribe-Ramírez, M., González-Pozos, S., Lozano, O., Lucas, S., & De Vizcaya-Ruiz, A.